Newswise Feature Channel: Respiratory Diseases and Disorders

Ozone Therapy: A New Breath of Life for Sepsis-Induced Lung Injury

Chinese Academy of Sciences — Fri, 27 Dec 2024 07:35:46 EST

A cutting-edge study has identified medical ozone therapy as a promising new treatment for sepsis-induced acute lung injury (ALI). By enhancing the clearance of neutrophil extracellular traps (NETs) through the AMP-activated protein kinase (AMPK)/scavenger receptor A1 (SR-A1) pathway, this innovative approach could significantly improve survival rates and lung function in preclinical models, offering hope for patients with limited treatment options.

Faster Lung Function Decline in Cystic Fibrosis Linked to High Sputum Levels of Pf Bacteriophage

Children's Hospital Los Angeles — Thu, 19 Dec 2024 21:15:20 EST

A Children's Hospital Los Angeles study has found that a virus that infects a common bacteria may lead to accelerated loss of lung function in individuals with cystic fibrosis (CF).

Top Cancer Research Advances at MSK in 2024

Memorial Sloan Kettering Cancer Center — Tue, 17 Dec 2024 12:00:16 EST

Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights into human biology and disease.

Exposure to Remote Wildfire Smoke Drifting Across the U.S. Linked to Increased Medical Visits for Heart and Lung Problems

University of Maryland School of Medicine — Fri, 13 Dec 2024 17:20:07 EST

New Study Found Increased Medical Visits for Heart and Respiratory Problems in Baltimore on Poor Air Quality Days from Western Canadian Wildfires

Asthma More Prevalent Among Children with Primary Ciliary Dyskinesia

Indiana University — Thu, 12 Dec 2024 20:20:18 EST

Researchers have found that children with primary ciliary dyskinesia, a rare genetic disorder affecting airway function, are significantly more likely than children without PCD to have asthma.

Rutgers Health Forms Corps to Clear the Air About Asthma

Rutgers University-New Brunswick — Wed, 11 Dec 2024 12:15:18 EST

An initiative headed by the Ernest Mario School of Pharmacy at Rutgers aims to use education to end pediatric asthma deaths in Newark, NJ, and beyond

ASH Presentation: Study Shows That Genetic Mutations Accumulate in Smokers with Myelodysplastic Syndromes and Worsen Outcomes

Sylvester Comprehensive Cancer Center — Mon, 09 Dec 2024 21:00:00 EST

Smokers with myelodysplastic syndromes or a precursor condition had elevated levels of genetic mutations linked to the disease. The study also found that heavier smokers accumulated more mutations, and long-term smokers were more likely to show disease progression.

EPA Study Finds That U.S. Public Schools with the Highest Potential Exposure Risk to Air Toxics Have Higher Proportions of Disabled Latino, Hispanic, and Asian Children

Society for Risk Analysis (SRA) — Mon, 09 Dec 2024 16:00:00 EST

The Environmental Protection Agency (EPA) has completed a nationwide study to assess the estimated non-cancer exposure risks of public school students to ambient air respiratory toxicants. The analysis also examined how disability status, race, and ethnicity were related to exposure risk in more than 88,000 regular public schools located in the 50 states, Washington D.C., and Puerto Rico.

Respiratory Illness Season is in Full Swing

George Washington University — Mon, 09 Dec 2024 13:55:35 EST

Researchers are Going to Map Cells Crucial to Child Respiratory Health and Disease

University of North Carolina School of Medicine — Fri, 06 Dec 2024 15:50:44 EST

A research project co-led by researchers at the UNC School of Medicine and colleagues, will create an atlas of the cells in the nasal and oral cavities, throat, and lower airways of pediatric populations in unprecedented detail.

Johns Hopkins Medicine Awarded More Than $18 Million for Creation of New ECMO and Life-Support System

Johns Hopkins Medicine — Thu, 05 Dec 2024 12:00:38 EST

Johns Hopkins Medicine has been awarded more than $18 million from the Defense Advanced Research Projects Agency (DARPA) to lead a multi-institutional effort to develop a novel extracorporeal membrane oxygenation (ECMO) and advanced life-support system device. ECMO devices assist patients by enabling heart and lung function when their organs are too damaged or weak to function normally.

The Fate of Airborne Microfibers in the Human Respiratory Tract in Different Microenvironments

National Center For Scientific Research Demokritos — Tue, 03 Dec 2024 14:00:51 EST

Rutgers Inventors Honored with Edison Patent Awards in Industrial Processes, Medical Diagnostics Categories

Rutgers University's Office for Research — Wed, 27 Nov 2024 10:05:17 EST

A catalyst that converts waste CO₂ to chemical products. A monoclonal antibody that could revolutionize the detection of tuberculosis. Both innovations were developed at Rutgers, The State University of New Jersey, and both received 2024 Edison Patent Awards at the annual Research & Development (R&D) Council of New Jersey (RDNJ) banquet.

For People Living with HIV/AIDS, TB is Still the Leading Cause of Death

American Thoracic Society (ATS) — Wed, 27 Nov 2024 10:00:54 EST

The latest World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995. TB is the leading cause of death among those with HIV /AIDS worldwide. According to the WHO, in 2023, 161,000 people died of HIV-associated TB.

Rutgers Tobacco & Nicotine Expert Available to Discuss Supreme Court Order on Graphic Cigarette Warnings

Rutgers University-New Brunswick — Tue, 26 Nov 2024 15:40:04 EST

Diabetes Drug Appears to Fight Lung Cancer -- But Only in Overweight or Obese Patients

Roswell Park Comprehensive Cancer Center — Tue, 26 Nov 2024 08:00:50 EST

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.

Healthcare to Research: The Many Ways Genetic Counselors Help Patients and Families

Ann and Robert H. Lurie Children's Hospital of Chicago — Mon, 25 Nov 2024 12:00:26 EST

Genetic counselors are experts in genetics and how it impacts our health and development. Learn more about who they are, what they do and how they may help you and your family....

More Patients Opting for Close Monitoring of Early Stage Prostate Cancer

Yale Cancer Center/Smilow Cancer Hospital — Fri, 22 Nov 2024 11:50:44 EST

Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of aggressiveness. It's also the second leading cause of cancer death, behind only lung cancer. A new study led by Yale Cancer Center researchers at Yale School Medicine found a substantial increase in the adoption of active surveillance (AS) and watchful waiting (WW) treatment strategies over the past decade -- an encouraging trend for men seeking less invasive treatment options.

Rutgers Health Expert Available: WHO Announces TB as Leading Cause of Death

Rutgers University-New Brunswick — Fri, 22 Nov 2024 11:50:33 EST

New Research Shows Younger and Middle-Aged Adults Have Worse Long COVID Symptoms Than Older Adults

Northwestern Medicine — Fri, 22 Nov 2024 05:00:00 EST

Since older adults have been more severely affected by acute COVID-19, researchers have hypothesized that older adults may have worse long COVID symptoms as well. But according to new research published in the Annals of Neurology, an official journal of the American Neurological Association, Northwestern Medicine researchers found on an average of 10 months after COVID-19 onset, younger (ages 18-44) and middle-aged (ages 45-64) adults had worse neurologic symptoms of long COVID than adults 65 and older. Symptoms included headache, numbness and tingling, problems with smell and taste, blurred vision, depression, anxiety, insomnia, fatigue and a decrease in cognitive function. These symptoms occurred regardless of if the patient had mild or severe COVID-19 infections.